Physician profile

Steve S Lin

Interventional Cardiology · Lexington, KY

NPI 1518979111

$362,338.84

in general payments reported to CMS, 2019-2025

48 companies · $68K in 2025

The $68K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$163,106.44
Travel and Lodging$12,775.50
Food and Beverage$9,664.76
Honoraria$4,500.00
Education$177.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $250,596.11 2019-2025 Wegovy, Ozempic, Rybelsus
Boehringer Ingelheim Pharmaceuticals, INC. $40,452.43 2019-2025 Jardiance
Janssen Pharmaceuticals, INC $27,727.94 2019-2023 Xarelto
Lilly USA, LLC $14,688.34 2019-2025 Jardiance
Astrazeneca Pharmaceuticals LP $9,614.83 2019-2025 Lokelma, Farxiga, Brilinta
Scpharmaceuticals INC. $4,736.50 2023-2025
Penumbra, INC. $4,387.50 2020-2025 Indigo System
Abiomed $1,776.24 2019-2025 Impella
Medtronic, INC. $1,243.67 2024 Onyx Frontier
Abbott Laboratories $959.54 2019-2025 Cardiomems
Terumo Medical Corporation $920.19 2022
Novartis Pharmaceuticals Corporation $753.62 2019-2025
Pfizer INC. $697.23 2019-2025
E.R. Squibb & Sons, L.L.C. $399.78 2019-2025 Camzyos, Eliquis
Amgen INC. $399.04 2019-2025 Repatha, Repatha
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $308.49 2021-2025 Verquvo, Capvaxive
Medtronic Vascular, INC. $264.39 2019-2020
Heartflow, INC. $243.17 2023 Ffrct
Inari Medical, INC. $242.88 2020-2021
Boston Scientific Corporation $232.81 2020-2025 Bodyguardian, Varithena Administration Pack, Cds - Mct/Cem Monitoring
Sanofi-Aventis U.S. LLC $186.43 2019-2022
Alnylam Pharmaceuticals INC. $165.44 2023-2025 Amvuttra, Onpattro
Amarin Pharma, INC. $165.21 2019-2020
Avinger INC. $133.68 2023 Pantheris
Bayer Healthcare Pharmaceuticals INC. $117.15 2022-2025
Akcea Therapeutics, INC. $107.44 2019
Kestra Medical Technology Services, INC. $95.86 2025 Assure Wcd
Esperion Therapeutics, INC. $94.64 2020-2025 Nexletol
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $94.24 2019-2024 Lifevest
Baxter Healthcare $73.25 2023 Hillrom - Carnation Ambulatory Monitor
Janssen Scientific Affairs, LLC $71.42 2020
Actelion Pharmaceuticals US, INC. $50.53 2019-2023 Uptravi, Opsumit
Lexicon Pharmaceuticals, INC. $45.27 2024
Lundbeck LLC $36.03 2019
Philips North America LLC $32.27 2023-2024 (5091) Amb Mon & Diag Und
Biocompatibles, INC. $30.32 2019
Regeneron Healthcare Solutions, INC. $23.46 2019
Irhythm Technologies, INC. $23.32 2023 Zio Xt Patch
Impulse Dynamics (USA) INC. $19.52 2023 Optimizer
Corcept Therapeutics $18.28 2025 Korlym
Cook Medical LLC $17.12 2021
Atricure, INC. $15.87 2024
Kiniksa Pharmaceuticals International, Plc $15.71 2024 Arcalyst
Angiodynamics, INC. $14.95 2021
Gilead Sciences, INC. $12.66 2019
Arbor Pharmaceuticals, INC. $12.50 2019
Preventice Services, LLC $12.23 2021
Surmodics, INC. $9.34 2024 Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steve S Lin

$362,338.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $68K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/205181/steve-s-lin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.